2,115
Views
12
CrossRef citations to date
0
Altmetric
Original Article

High-density and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm

, ORCID Icon, , , &
Pages 1597-1603 | Received 10 Aug 2018, Accepted 29 Sep 2018, Published online: 03 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Paula Meleady, Rozana Abdul Rahman, Michael Henry, Michael Moriarty & Martin Clynes. (2020) Proteomic analysis of pancreatic ductal adenocarcinoma. Expert Review of Proteomics 17:6, pages 453-467.
Read now

Articles from other publishers (11)

Abdullah Esmail, Mohamed Badheeb & Maen Abdelrahim. 2023. Pancreatic Cancer- Updates in Pathogenesis, Diagnosis and Therapies. Pancreatic Cancer- Updates in Pathogenesis, Diagnosis and Therapies.
Yu Pu, Helin Ke, Changqiang Wu, Shaodan Xu, Yang Xiao, Lina Han, Guorong Lyu & Shilin Li. (2023) Superparamagnetic iron oxide nanoparticles target BxPC-3 cells and silence MUC4 for the treatment of pancreatic cancer. Biochimica et Biophysica Acta (BBA) - General Subjects 1867:9, pages 130383.
Crossref
Pratima Raut, Rama Krishna Nimmakayala, Surinder K. Batra & Moorthy P. Ponnusamy. (2023) Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:1, pages 188851.
Crossref
Mohamed Badheeb, Adham Abdelrahim, Abdullah Esmail, Godsfavour Umoru, Karen Abboud, Ebtesam Al-Najjar, Ghaith Rasheed, Mohammed Alkhulaifawi, Ala Abudayyeh & Maen Abdelrahim. (2022) Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening. Current Oncology 29:11, pages 8693-8719.
Crossref
Wei Qin, Jing Zhang, Ruixue Rong, Litao Zhang, Huijie Gao, Chao Liu, Qiang Ren, Gongpu Zheng, Jian Wang, Lingxin Meng, Sen Qiao, Ruikun Qian, Caiju Zhou, Huiyun Wang & Yuntao Zhang. (2022) Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. Tissue and Cell 78, pages 101867.
Crossref
Xing Huang, Yipeng Feng, Dawei Ma, Hanlin Ding, Gaochao Dong, Yan Chen, Xiaochen Huang, Jingyuan Zhang, Xinyu Xu & Chen Chen. (2022) The molecular, immune features, and risk score construction of intraductal papillary mucinous neoplasm patients. Frontiers in Molecular Biosciences 9.
Crossref
Jinshou Yang, Ruiyuan Xu, Chengcheng Wang, Jiangdong Qiu, Bo Ren & Lei You. (2021) Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Cancer Communications 41:12, pages 1257-1274.
Crossref
Randa G. Hanna-Sawires, Jorinde H. Schiphuis, Manfred Wuhrer, Hans F. A. Vasen, Monique E. van Leerdam, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt & Rob A. E. M. Tollenaar. (2021) Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. International Journal of Molecular Sciences 22:5, pages 2655.
Crossref
Katherine S. Yang, Debora Ciprani, Aileen O’Shea, Andrew S. Liss, Robert Yang, Sarah Fletcher-Mercaldo, Mari Mino-Kenudson, Carlos Fernández-del Castillo & Ralph Weissleder. (2021) Extracellular Vesicle Analysis Allows for Identification of Invasive IPMN. Gastroenterology 160:4, pages 1345-1358.e11.
Crossref
Hui-min Liu, Le-le Ma, Bo Cao, Jun-zhi Lin, Li Han, Chun-yu Li, Run-chun Xu & Ding-kun Zhang. (2021) Progress in research into the role of abnormal glycosylation modification in tumor immunity. Immunology Letters 229, pages 8-17.
Crossref
Damiano Caputo & Giulio Caracciolo. (2020) Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma. Cancer Letters 470, pages 191-196.
Crossref